Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Brain receptors
Muscarinic Pathways in Schizophrenia: Unlocking New Therapeutic Targets
Neuron
CME: Meet Me at the Water Cooler: Schizophrenia
Patient and provider
CME: End of the Anticholinergic Era? Challenging Cases in Anticholinergic Deprescribing: Real-World Scenarios (Module 4)
Patient and provider
CME: End of the Anticholinergic Era? Deprescribing with Confidence: Strategies for Safe Medication Changes (Module 3)
Woman taking medication
CME: End of the Anticholinergic Era? Measuring the Impact: Understanding Anticholinergic Burden (Module 2)
Muscarinic Receptor
CME: I Love Muscarinic Control! Targeting the Muscarinic System in the Treatment of Schizophrenia
Medication
CME: End of the Anticholinergic Era? Breaking Down the Anticholinergic System: Risks and Realities (Module 1)
Medication
CME: Psychopharmacolojourney: A Look at How Far We Have Come and Where We Might Go
Patient and provider
Schizophrenia Unfiltered, Part 3: Pathways to Novel Treatment 
Ins and Outs title slide
Ins and Outs of Antipsychotic Therapy for Schizophrenia

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy